Medtronic issued a press release summarizing the results of the 780G pivotal trial.
Evidently the 780G can be set for a target BG of 100, and doesn’t require as many calibrations. It says the people in the trial stayed in closed-loop 95% of the time. Average A1C when looping was 7.0, overall time in range (70-180) was 75%.
4 Likes
Well it seems they have potentially caught back up in the commercially released systems. Wonder how much better it would be if they also allowed the use of Dexcom.
2 Likes